Lattice Semiconductor price target raised to $80 at Raymond James

Investing.comTuesday, November 4, 2025 at 10:35:06 AM
Lattice Semiconductor price target raised to $80 at Raymond James
Lattice Semiconductor has received a price target increase to $80 from Raymond James, reflecting strong confidence in the company's growth potential. This adjustment is significant as it highlights the positive outlook for Lattice's future performance, which could attract more investors and boost market interest.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Raymond James reiterates Market Perform on Palantir stock despite strong Q3
NeutralFinancial Markets
Raymond James has maintained a Market Perform rating on Palantir's stock, even after the company reported strong results for the third quarter. This decision reflects a cautious approach, suggesting that while Palantir's performance is commendable, there may be underlying concerns or market conditions that warrant a more reserved outlook. Investors should consider this perspective as they evaluate their positions in the stock.
Liquidia stock price target raised to $47 from $41 at Raymond James
PositiveFinancial Markets
Liquidia's stock price target has been raised from $41 to $47 by Raymond James, indicating strong confidence in the company's future performance. This adjustment reflects the analysts' positive outlook on Liquidia's growth potential and could attract more investors, boosting the stock's value.
Lattice Semiconductor Q3 2025 slides: revenue up 7.6%, AI drives growth
PositiveFinancial Markets
Lattice Semiconductor has reported a 7.6% increase in revenue for Q3 2025, driven largely by advancements in artificial intelligence. This growth highlights the company's strong position in the semiconductor market and its ability to leverage AI technologies to enhance its product offerings. As AI continues to be a significant driver of innovation, Lattice's performance is a positive indicator for investors and the tech industry as a whole.
Cigna price target lowered to $350 by Raymond James on PBM contract changes
NegativeFinancial Markets
Cigna's price target has been lowered to $350 by Raymond James due to changes in its pharmacy benefit management (PBM) contracts. This adjustment reflects concerns about the company's future profitability and market position, which could impact investors' confidence and the stock's performance. Understanding these shifts is crucial for stakeholders as they navigate the evolving landscape of healthcare management.
Shake Shack stock reaffirmed at Strong Buy by Raymond James on Big Shack launch
PositiveFinancial Markets
Raymond James has reaffirmed its 'Strong Buy' rating for Shake Shack's stock, especially following the launch of their new Big Shack burger. This endorsement is significant as it highlights investor confidence in the brand's growth potential and innovative menu offerings, which could attract more customers and boost sales.
Agreements made at Trump-Xi meeting are "overall positive," Raymond James says
PositiveFinancial Markets
The recent meeting between Trump and Xi has been deemed 'overall positive' by Raymond James, highlighting the potential for improved trade relations between the U.S. and China. This is significant as it could lead to a reduction in tariffs and foster a more stable economic environment, benefiting businesses and consumers alike.
Universal Health Services stock rating upgraded to Outperform by Raymond James
PositiveFinancial Markets
Universal Health Services has received an upgrade to an 'Outperform' rating from Raymond James, signaling strong confidence in the company's future performance. This upgrade is significant as it reflects analysts' positive outlook on the healthcare sector, particularly for Universal Health Services, which is poised for growth. Investors may find this news encouraging as it suggests potential for increased stock value and improved financial health for the company.
Raymond James upgrades Edwards Lifesciences stock rating to Outperform
PositiveFinancial Markets
Raymond James has upgraded its rating for Edwards Lifesciences to 'Outperform', indicating strong confidence in the company's future performance. This upgrade is significant as it reflects the firm's belief in Edwards' growth potential, particularly in the medical technology sector, which could lead to increased investor interest and potentially higher stock prices.
Latest from Financial Markets
What to Know About SNAP Amid Fight Over Funding
NegativeFinancial Markets
The ongoing debate over SNAP funding has created significant anxiety among recipients, retailers, and food banks, as the possibility of suspended or delayed payments looms. This situation is critical because it affects millions who rely on these benefits for their daily sustenance, highlighting the urgent need for a resolution to ensure food security for vulnerable populations.
Restaurant group with a 115-year history files Chapter 11 bankruptcy
NegativeFinancial Markets
A historic restaurant group with 115 years of service has filed for Chapter 11 bankruptcy, highlighting the ongoing challenges in the seafood industry. The high costs of sourcing and shipping seafood have made it difficult for many establishments to thrive. This situation not only affects the employees and owners but also reflects broader economic pressures on the restaurant sector, particularly for those specializing in expensive ingredients.
Move to reduce fuel duty increase fails
NegativeFinancial Markets
The recent proposal by Policy and Resources to increase fuel duty by 4.3% has faced significant opposition and ultimately failed. This decision is crucial as it directly impacts consumers and businesses, potentially leading to higher transportation costs and affecting the overall economy.
This Will Be the COP30 ‘Of Truth,’ Do Lago Says
NeutralFinancial Markets
COP30 President Andre Correa do Lago expressed his views on the absence of the American government at the upcoming COP30 summit in Brazil. He noted that while the US economy will still be represented through businesses and universities, he would have preferred a direct government presence. This highlights the ongoing discussions about the role of government versus private entities in addressing climate change, making it a significant point of consideration for the summit.
Correction
NeutralFinancial Markets
David Bookbinder has stepped down from representing Boulder County, Colorado, in its ongoing climate lawsuit against Suncor Energy and Exxon Mobil. This change in legal representation could impact the county's strategy and approach in the case, which is significant as it addresses the pressing issues of climate change and corporate accountability.
Embraer ADR earnings beat by $0.16, revenue topped estimates
PositiveFinancial Markets
Embraer has reported earnings that exceeded expectations by $0.16, along with revenues that topped estimates. This positive financial performance highlights the company's strong market position and effective management strategies, which are crucial for attracting investors and boosting confidence in the aerospace sector.